CpG island methylator phenotype (CIMP) can result in the silencing of key genes important for tumor progression, including the tumor‐suppressor gene, CDKN2A, and the DNA mismatch repair gene, MLH1. This evidence concerns the gene CDKN2A and neoplasm.